ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.266,22
0,64%
S&P 500
5.819,33
-0,29%
Dow Jones
42.237,30
-0,14%
Euro vs US Dollar
1,0297
0,31%
Bitcoin
95.606,18
1,16%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cartesian Therapeutics Inc (RNAC)

  7. Cartesian Therapeutics Inc (RNAC) News

RNAC

Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RNAC
DatumZeitQuelleÜberschriftSymbolFirma
14/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
14/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
13/01/202522h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
13/01/202513h00GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune DiseasesNASDAQ:RNACCartesian Therapeutics Inc
10/01/202512h01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RNACCartesian Therapeutics Inc
10/01/202512h00Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RNACCartesian Therapeutics Inc
10/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
10/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
10/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
08/01/202522h38Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RNACCartesian Therapeutics Inc
08/01/202522h33Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RNACCartesian Therapeutics Inc
08/01/202522h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
08/01/202502h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
07/01/202513h05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
06/01/202522h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
30/12/202422h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
30/12/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RNAC

Kürzlich von Ihnen besucht

DBI
DAX
DAX
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
AMEX
XLF
Financial Select Sector
TG
DTE
Deutsche Telekom
AMEX
XLV
Health Care Select Sector
TG
NOV
Novo Nordisk
NYSE
NKE
Nike
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
TG
ALV
Allianz
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten